Bora Pharmaceuticals calls second domestic convertible bonds

By William Gullotti

Buffalo, N.Y., Oct. 5 – Bora Pharmaceuticals Co., Ltd. will exercise its redemption rights for its second domestic unsecured convertible corporate bonds at par on Oct. 16, according to a notice on Thursday.

Bondholders who do not apply for common stock conversion with the stock affair agent prior to the Oct. 17 deadline will receive the face value of the convertibles.

The notice was issued to prevent investors who may acquire the still-trading bonds at a higher price than the face value to incur loss by not applying for conversion.

The stock affair agent is Taishin Securities (02 2504-8125; B1, No. 96, Jianguo North Road, Section 1, Zhongshan District, Taipei City 104).

Bora Pharmaceuticals is a pharmaceutical company based in Taipei, Taiwan.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.